Shagun Singh
Stock Analyst at RBC Capital
(3.34)
# 1,025
Out of 4,753 analysts
189
Total ratings
50.93%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $425 → $435 | $392.39 | +10.86% | 19 | Jan 29, 2025 | |
| JNJ Johnson & Johnson | Reiterates: Outperform | $181 | $153.49 | +17.92% | 16 | Jan 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Outperform | $135 | $129.10 | +4.57% | 12 | Jan 23, 2025 | |
| OM Outset Medical | Reiterates: Sector Perform | $3 | $0.82 | +265.85% | 9 | Jan 7, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $80 → $85 | $71.33 | +19.16% | 20 | Dec 5, 2024 | |
| NVRO Nevro | Reiterates: Sector Perform | $7 | $5.13 | +36.45% | 9 | Nov 12, 2024 | |
| GMED Globus Medical | Maintains: Outperform | $80 → $92 | $92.18 | -0.20% | 5 | Nov 6, 2024 | |
| INSP Inspire Medical Systems | Reiterates: Outperform | $260 | $197.38 | +31.73% | 3 | Nov 5, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $120 → $125 | $107.80 | +15.96% | 12 | Nov 4, 2024 | |
| TFX Teleflex | Maintains: Outperform | $275 → $245 | $174.90 | +40.08% | 19 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $87.46 | +31.49% | 4 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $98 | $103.54 | -5.35% | 13 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $555 | $579.65 | -4.25% | 13 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $98 → $105 | $90.97 | +15.42% | 19 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $11 | $8.06 | +36.48% | 5 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $205 → $222 | $262.11 | -15.30% | 10 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $35.99 | +80.61% | 1 | Oct 2, 2024 |
Stryker
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $392.39
Upside: +10.86%
Johnson & Johnson
Jan 23, 2025
Reiterates: Outperform
Price Target: $181
Current: $153.49
Upside: +17.92%
Abbott Laboratories
Jan 23, 2025
Reiterates: Outperform
Price Target: $135
Current: $129.10
Upside: +4.57%
Outset Medical
Jan 7, 2025
Reiterates: Sector Perform
Price Target: $3
Current: $0.82
Upside: +265.85%
Edwards Lifesciences
Dec 5, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $71.33
Upside: +19.16%
Nevro
Nov 12, 2024
Reiterates: Sector Perform
Price Target: $7
Current: $5.13
Upside: +36.45%
Globus Medical
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $92.18
Upside: -0.20%
Inspire Medical Systems
Nov 5, 2024
Reiterates: Outperform
Price Target: $260
Current: $197.38
Upside: +31.73%
Zimmer Biomet Holdings
Nov 4, 2024
Maintains: Outperform
Price Target: $120 → $125
Current: $107.80
Upside: +15.96%
Teleflex
Nov 1, 2024
Maintains: Outperform
Price Target: $275 → $245
Current: $174.90
Upside: +40.08%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $87.46
Upside: +31.49%
Oct 24, 2024
Maintains: Outperform
Price Target: $95 → $98
Current: $103.54
Upside: -5.35%
Oct 18, 2024
Maintains: Outperform
Price Target: $525 → $555
Current: $579.65
Upside: -4.25%
Oct 10, 2024
Upgrades: Outperform
Price Target: $98 → $105
Current: $90.97
Upside: +15.42%
Oct 8, 2024
Maintains: Outperform
Price Target: $12 → $11
Current: $8.06
Upside: +36.48%
Oct 8, 2024
Maintains: Outperform
Price Target: $205 → $222
Current: $262.11
Upside: -15.30%
Oct 2, 2024
Initiates: Outperform
Price Target: $65
Current: $35.99
Upside: +80.61%